These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
475 related articles for article (PubMed ID: 30520951)
1. Role of Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease. Lovisa S; Genovese G; Danese S J Crohns Colitis; 2019 Apr; 13(5):659-668. PubMed ID: 30520951 [TBL] [Abstract][Full Text] [Related]
2. Down-regulation of microRNAs of the miR-200 family and up-regulation of Snail and Slug in inflammatory bowel diseases - hallmark of epithelial-mesenchymal transition. Zidar N; Boštjančič E; Jerala M; Kojc N; Drobne D; Štabuc B; Glavač D J Cell Mol Med; 2016 Oct; 20(10):1813-20. PubMed ID: 27113480 [TBL] [Abstract][Full Text] [Related]
4. Controversial Contribution of Th17/IL-17 Toward the Immune Response in Intestinal Fibrosis. Latella G; Viscido A Dig Dis Sci; 2020 May; 65(5):1299-1306. PubMed ID: 32124197 [TBL] [Abstract][Full Text] [Related]
5. Effect and Mechanism of TL1A Expression on Epithelial-Mesenchymal Transition during Chronic Colitis-Related Intestinal Fibrosis. Wenxiu J; Mingyue Y; Fei H; Yuxin L; Mengyao W; Chenyang L; Jia S; Hong Z; Shih DQ; Targan SR; Xiaolan Z Mediators Inflamm; 2021; 2021():5927064. PubMed ID: 34257516 [TBL] [Abstract][Full Text] [Related]
6. MiR-21 regulates epithelial-mesenchymal transition in intestinal fibrosis of Crohn's disease by targeting PTEN/mTOR. Wang Z; Zhou H; Cheng F; Zhang Z; Long S Dig Liver Dis; 2022 Oct; 54(10):1358-1366. PubMed ID: 35504804 [TBL] [Abstract][Full Text] [Related]
7. Vitamin D receptor inhibits EMT via regulation of the epithelial mitochondrial function in intestinal fibrosis. Yu M; Wu H; Wang J; Chen X; Pan J; Liu P; Zhang J; Chen Y; Zhu W; Tang C; Jin Q; Li C; Lu C; Zeng H; Yu C; Sun J J Biol Chem; 2021; 296():100531. PubMed ID: 33713706 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of initiation and progression of intestinal fibrosis in IBD. Latella G; Di Gregorio J; Flati V; Rieder F; Lawrance IC Scand J Gastroenterol; 2015 Jan; 50(1):53-65. PubMed ID: 25523556 [TBL] [Abstract][Full Text] [Related]
9. Fibrogenesis. IV. Fibrosis and inflammatory bowel disease: cellular mediators and animal models. Pucilowska JB; Williams KL; Lund PK Am J Physiol Gastrointest Liver Physiol; 2000 Oct; 279(4):G653-9. PubMed ID: 11005750 [TBL] [Abstract][Full Text] [Related]
10. Evidence for a role of epithelial mesenchymal transition during pathogenesis of fistulae in Crohn's disease. Bataille F; Rohrmeier C; Bates R; Weber A; Rieder F; Brenmoehl J; Strauch U; Farkas S; Fürst A; Hofstädter F; Schölmerich J; Herfarth H; Rogler G Inflamm Bowel Dis; 2008 Nov; 14(11):1514-27. PubMed ID: 18626977 [TBL] [Abstract][Full Text] [Related]
11. Epithelial-mesenchymal transition in Crohn's disease. Jiang H; Shen J; Ran Z Mucosal Immunol; 2018 Mar; 11(2):294-303. PubMed ID: 29346350 [TBL] [Abstract][Full Text] [Related]
12. Immunological Regulation of Intestinal Fibrosis in Inflammatory Bowel Disease. Bamias G; Pizarro TT; Cominelli F Inflamm Bowel Dis; 2022 Mar; 28(3):337-349. PubMed ID: 34904152 [TBL] [Abstract][Full Text] [Related]
13. Role of the epithelial barrier in intestinal fibrosis associated with inflammatory bowel disease: relevance of the epithelial-to mesenchymal transition. Macias-Ceja DC; Mendoza-Ballesteros MT; Ortega-Albiach M; Barrachina MD; Ortiz-Masià D Front Cell Dev Biol; 2023; 11():1258843. PubMed ID: 37822869 [TBL] [Abstract][Full Text] [Related]
14. A role for tumor necrosis factor and bacterial antigens in the pathogenesis of Crohn's disease-associated fistulae. Frei SM; Pesch T; Lang S; Weber A; Jehle E; Vavricka SR; Fried M; Rogler G; Scharl M Inflamm Bowel Dis; 2013 Dec; 19(13):2878-87. PubMed ID: 24189042 [TBL] [Abstract][Full Text] [Related]
15. Anti-fibrogenic Potential of Mesenchymal Stromal Cells in Treating Fibrosis in Crohn's Disease. Lian L; Huang Q; Zhang L; Qin H; He X; He X; Ke J; Xie M; Lan P Dig Dis Sci; 2018 Jul; 63(7):1821-1834. PubMed ID: 29704139 [TBL] [Abstract][Full Text] [Related]
16. Role of non-inflammatory factors in intestinal fibrosis. Zhao JF; Ling FM; Li JR; Chen YD; Huang L; Zhu LR J Dig Dis; 2020 Jun; 21(6):315-318. PubMed ID: 32406603 [TBL] [Abstract][Full Text] [Related]
17. Total flavone of Yang BL; Zhu P; Li YR; Xu MM; Wang H; Qiao LC; Xu HX; Chen HJ World J Gastroenterol; 2018 Aug; 24(30):3414-3425. PubMed ID: 30122880 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of epithelial SHH signaling exerts a dual protective effect against inflammation and epithelial-mesenchymal transition in inflammatory bowel disease. Ghorbaninejad M; Meyfour A; Maleknia S; Shahrokh S; Abdollahpour-Alitappeh M; Asadzadeh-Aghdaei H Toxicol In Vitro; 2022 Aug; 82():105382. PubMed ID: 35569705 [TBL] [Abstract][Full Text] [Related]
19. Epithelial-mesenchymal transition and its role in the pathogenesis of colorectal cancer. Zhu QC; Gao RY; Wu W; Qin HL Asian Pac J Cancer Prev; 2013; 14(5):2689-98. PubMed ID: 23803016 [TBL] [Abstract][Full Text] [Related]
20. Interleukin-13 and transforming growth factor β synergise in the pathogenesis of human intestinal fistulae. Scharl M; Frei S; Pesch T; Kellermeier S; Arikkat J; Frei P; Fried M; Weber A; Jehle E; Rühl A; Rogler G Gut; 2013 Jan; 62(1):63-72. PubMed ID: 22287592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]